Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Bladder exstrophy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Bladder exstrophy indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Vesicoureteral reflux Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Vesicoureteral reflux strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Prune belly syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Prune belly syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Exstrophy-epispadias complex Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Exstrophy-epispadias complex strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Pelvic organ prolapse Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Pelvic organ prolapse strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Nocturia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Nocturia indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Nocturnal enuresis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Nocturnal enuresis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Urge urinary incontinence Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Urge urinary incontinence strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Mixed urinary incontinence Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Mixed urinary incontinence strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Stress urinary incontinence Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Stress urinary incontinence strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Underactive bladder Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Underactive bladder indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Neurogenic bladder Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Neurogenic bladder indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.